ArticleInternal medicine (Tokyo, Japan)2021

Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?

Ritesh Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.